APVO436
APVO436-5201
Phase 1 small_molecule active
Quick answer
APVO436 for Acute Myeloid Leukemia (AML) is a Phase 1 program (small_molecule) at Aptevo Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aptevo Therapeutics
- Indication
- Acute Myeloid Leukemia (AML)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active